Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/28/2007CN100351268C Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers
11/28/2007CN100351267C Human urine anti-tumor (antibacterial) peptide, its preparation and use
11/28/2007CN100351260C Polysaccharide vaccine for staphylococcal infections
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350972C Vaccines comprising aluminium adjuvants and histidine
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/27/2007US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007US7300785 Culturing circular ssDNA viruses for the production of vaccines
11/27/2007US7300774 Injected locally as a vaccine adjuvant or tumor immunotherapy agent to prevent them from diffusing away
11/27/2007US7300765 SC6 for diagnosis of cancers
11/27/2007US7300660 immunogens/vaccines against mycobactium tuberculosis
11/27/2007US7300659 Comprising an enterohemorragic Escherichia coli (EHEC) cell culture supernatant and an immunological adjuvant
11/27/2007US7300658 For use in vaccines
11/27/2007US7300657 Recombinant viral-based malaria vaccines
11/27/2007US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007US7300651 Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
11/27/2007US7300650 Reovirus for the treatment of neoplasia
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2271683C Coated particles, methods of making and using
11/27/2007CA2167274C Inactivated respiratory syncytial viral vaccines
11/22/2007WO2007134327A2 Neutralizing antibodies to influenza viruses
11/22/2007WO2007134282A2 Stroller with spring-assisted fold mechanism
11/22/2007WO2007134147A2 Method of vaccinating subjects receiving immune modulating therapy
11/22/2007WO2007134007A2 Aminated materials for assays
11/22/2007WO2007133972A2 Mixing and dispensing granular food products and liquid
11/22/2007WO2007133773A2 Identification of cdki pathway inhibitors
11/22/2007WO2007133772A2 Cdki pathway inhibitors as selective inhibitors of tumor cell growth
11/22/2007WO2007133516A1 Diagnostic methods for determining treatment
11/22/2007WO2007133147A1 Method and means for treating inflammatory bowel disease
11/22/2007WO2007132480A2 A composition useful as a vaccine
11/22/2007WO2007131972A1 Nicotine-carrier vaccine formulation
11/22/2007WO2007131363A1 Monoclonal antibodies to anthrax protective antigen
11/22/2007WO2007131293A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi
11/22/2007WO2007131292A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
11/22/2007WO2007131291A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
11/22/2007WO2007131286A1 Nanostructures suitable for delivery of agents
11/22/2007WO2007112750A3 Tablets and capsules comprising immunogens for oral administration
11/22/2007WO2007112702A3 Pharmaceutical composition containing the nmb0938 protein
11/22/2007WO2007111626A3 Arginase ii: a target for the prevention and treatment of atherosclerosis
11/22/2007WO2007103814A3 Angiogenesis pathway gene polymorphisms for therapy selection
11/22/2007WO2007089476A3 Chemoprevention of endometrial cancer
11/22/2007WO2007084559A3 Methods to treat disease states by influencing the signaling of ox40-receptors and high throughput screening methods for identifying substances therefor
11/22/2007WO2007076365A3 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection
11/22/2007WO2007076323A3 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
11/22/2007WO2007064882A3 Treatment of conditions involving demyelination
11/22/2007WO2007024649A3 Methods of treating and preventing acute myocardial infarction
11/22/2007WO2007021672A3 Vaccination against dengue virus infection
11/22/2007WO2007018671A3 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
11/22/2007WO2007016590A3 Ovr232v3 antibody compositions and methods of use
11/22/2007WO2006101486A3 Bacteriocins and novel bacterial strains
11/22/2007WO2006076525A3 Combination cancer therapy with anti-psma antibodies
11/22/2007WO2006052960A3 METHODS AND COMPOSITIONS FOR INCREASING STEM CELL HOMING USING Gαs ACTIVATORS
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005007673A3 Immunogenic peptides
11/22/2007WO2004039950A3 Activation of hcv-specific cells
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270362 Methods and compositions for prevention or treatment of inflammatory-related diseases and disorders
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070269861 Soluble recombinant botulinum toxin proteins
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269501 Immunotherapeutic Agent for the Combined Treatment of Tuberculosis in Association With Other Drugs
11/22/2007US20070269489 Extracorporeal cell-based therapeutic device and delivery system
11/22/2007US20070269479 Drug delivery; controlling the release of therapeutic agents from a medical device
11/22/2007US20070269464 Epitope synchronization in antigen presenting cells
11/22/2007US20070269463 Botulinum toxin formulation for oral administration
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269461 Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
11/22/2007US20070269460 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
11/22/2007US20070269459 Mutant G Genes of the Trout Viral Haemorrhagic Septicaemia Virus (Vhsv) and Applications Thereof
11/22/2007US20070269458 Vaccines Against Japanese Encephalitis Virus and West Nile Virus
11/22/2007US20070269457 Immunotherapeutic compositions and methods
11/22/2007US20070269456 DNA-based plasmid formulations and vaccines and prophylactics containing the same
11/22/2007US20070269455 Cytokine-coated cells and methods of modulating an immune response to an antigen
11/22/2007US20070269453 White spot syndrome virus peptide highly expressed in hosts, which comprises a peptide sequence and can be used as target peptide for white spot disease immunodetection; crustaceans; aquaculture industry; sensitivities of detection using target peptide in invention are greatly improved
11/22/2007US20070269452 Methods and compositions for the diagnosis and treatment of cancer
11/22/2007US20070269451 Nucleic Acid Vaccination
11/22/2007US20070269449 Fc Fusion Proteins
11/22/2007US20070269448 Transition State Analog Inhibitors Of Ricin A-Chain
11/22/2007US20070269447 Cytotoxic agents comprising new maytansinoids
11/22/2007US20070269446 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269444 Adjuvant Therapy with the Use of Anti-Glypican 3 Antibody
11/22/2007US20070269443 Therapeutic Regimens for Baff Antagonists
11/22/2007US20070269442 Chimeric monoclonal antibody recognizing iNOS
11/22/2007US20070269441 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/22/2007US20070269440 Stimulators of osteoblastogenesis and applications of the same
11/22/2007US20070269439 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
11/22/2007US20070269438 Antibodies to the Human Prolactin Receptor
11/22/2007US20070269437 Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
11/22/2007US20070269436 Method of Antibody Production
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269434 TAT-041 and methods of assessing and treating cancer
11/22/2007US20070269433 Cell cycle progressional proteins
1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 ... 1823